People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Cancer survivors diagnosed early in life may have unanswered questions about their sexual health.
by Lindsey Konkel
Cellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.
by Carisa D. Brewster
Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.
by Marci A. Landsmann
Facts and Stats
A knowledge of the different types of skin cancer can help you remain vigilant.
by Bradley Jones
Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
Authors make a call for anti-racist cancer research.
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
Learning Medicare’s ABCDs
donate to the AACR